Skip to main content

Table 3 Performance characteristics of Genotype MTBDRplus VER 2.0 LPA for detection RMP and INH resistance and MDR-TB in smear negative and culture positive direct sample, 2015

From: Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples

Detection of drug resistance

MGIT R

MGIT S

LPA R

LPA S

Sensitivity%

Specificity%

PPV%

NPV%

(95%* CI)

(95%* CI)

(95%* CI)

(95%* CI)

*RMP

3

11

7

7

100 (29.2–100)

63.6 (30.8–89.1)

42.9 (9.9–81.6)

100 (59–100)

*INH

5

9

3

11

60 (14.7–94.7)

100 (66.4–100)

100 (29.2–100)

81.8 (48.2–97.7)

*MDR-TB (RMP&INH)

2

5

2

5

100 (15.8–100)

100 (47.8–100)

100 (15.8–100)

100 (47.8–100)

  1. *RMP Rifampicin, INH Isoniazid, MDR-TB Multidrug resistant Tuberculosis, CI Confidence Interval